Baxter Phillips
Directeur des opérations chez LOBE SCIENCES LTD.
Fortune : 10 200 $ au 30/06/2024
Postes actifs de Baxter Phillips
Sociétés | Poste | Début | Fin |
---|---|---|---|
LOBE SCIENCES LTD. | Directeur/Membre du Conseil | 03/10/2022 | - |
Directeur des opérations | 07/06/2023 | - | |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 16/10/2018 | - |
Independent Dir/Board Member | - | - | |
Directeur Général | 16/10/2018 | - | |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | President | - | - |
Historique de carrière de Baxter Phillips
Anciens postes connus de Baxter Phillips
Sociétés | Poste | Début | Fin |
---|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Directeur Général | 01/10/2015 | 01/10/2017 |
President | 01/10/2015 | 01/10/2017 | |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Investor Relations Contact | 13/11/2013 | 27/05/2015 |
Corporate Officer/Principal | 13/11/2013 | 01/10/2015 | |
OSTEOLOGIX HOLDINGS PLC | Public Communications Contact | 06/05/2010 | 01/08/2011 |
Corporate Officer/Principal | 01/06/2007 | 06/05/2010 |
Formation de Baxter Phillips
Hampden-Sydney College | Undergraduate Degree |
Mason School of Business of The College of William & Mary | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Irlande | 2 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
President | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LOBE SCIENCES LTD. | Process Industries |
Entreprise privées | 5 |
---|---|
Osteologix Holdings Plc
Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | Health Technology |
- Bourse
- Insiders
- Baxter Phillips
- Expérience